Circulating immune complexes in patients with diabetes mellitus

Area of Science:

• Immunology
• Endocrinology
• Diabetology

Background:

• Circulating immune complexes (CIC) are implicated in various autoimmune and inflammatory conditions.
• Diabetes mellitus is associated with immune dysregulation, but the role of CIC in diabetes is not fully understood.

Purpose of the Study:

• To investigate the prevalence of CIC in diabetic patients using two different detection assays.
• To explore potential correlations between CIC levels and key diabetes-related parameters such as hyperglycemia, hyperinsulinemia, and microangiopathy.

Main Methods:

• Solid phase C1q binding assay and fluid phase C1q binding assay were employed to detect CIC.
• Plasma glucose and insulin levels were measured, and the presence of microangiopathy was assessed in 103 diabetic patients and 58 control subjects.

Main Results:

• CIC were detected in 16% of diabetic patients by solid phase assay and 31% by fluid phase assay, compared to 5% in controls for both assays.
• Most diabetic patients exhibited moderate hyperglycemia (mean glucose 264 mg/dl) and elevated plasma insulin levels.
• No significant correlation was found between CIC presence and plasma glucose, insulin levels, or microangiopathy.

Conclusions:

• Diabetic patients show an increased prevalence of CIC compared to healthy individuals.
• The elevated CIC levels in diabetes appear multifactorial, independent of glycemic control, insulin levels, or microangiopathy.
• Further research is needed to elucidate the specific contributing factors to CIC formation in diabetes.